Exact Mass: 407.98023700000005
Exact Mass Matches: 407.98023700000005
Found 59 metabolites which its exact mass value is equals to given mass value 407.98023700000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Antibiotic MM4550
C13H16N2O9S2 (408.02972059999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
6-Hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonic acid
Yellow food dye used in cereals, bakery products, sweets, snack foods, ice cream, drinks and canned fish.
(6E,8E,12E)-3-methylene-4-oxo-7,11-dimethyl-(10S*,11R*)-dichloro-13-bromotrideca-6,8,12-trienoic acid|Polyhalogenated homosesquiterpenic fatty acid A
(3Z,11Z,7S*,9R*,10R*)-6-chloro-9,13-dibromo-7:10-epoxypentadeca-3,11-dien-1-yne
13-bromo-10R,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
13-bromo-10S,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
2,5-BIS(3-(N,N-DIETHYLAMINO)-1-OXAPROPYL
C14H22Br2N2O2 (408.00479119999994)
(6-PYRROLIDIN-1-YLPYRID-2-YL)METHANOL
C10H12N6O6S3 (407.99804520000004)
Xanthosine 5-monophosphate sodium salt
C10H11N4Na2O9P (408.00590460000006)
Xanthosine 5'-monophosphate sodium salt (5'-Xanthylic acid sodium salt) is an intermediate in purine metabolism. Xanthosine 5'-monophosphate sodium salt can be used for genetic code, nucleic acid structure, and DNA, RNA and protein synthesis research[1].
ethyl 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylate
2,2-bis(3,5-difluoro-4-hydroxyphenyl)hexafluoropropane
3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide
C17H17IN2S (408.01571520000005)
Tranxene
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
(S)-2-Benzothiazolyl (Z)-2-(2-aminothiazole-4-yl)-2-methoxycarbonylmethoxyiminothioacetate
dipotassium 2-(6-oxido-3-oxoxanthen-9-yl)benzoate
C20H10K2O5 (407.98023700000005)
2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene
3-{[5-deoxy-5-(dimethylarsoryl)-
C10H21AsO10S (408.00713460000003)
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide
6-Hydroxy-5-((4-sulphophenyl)azo)naphthalene-2-sulphonic acid
D000074385 - Food Ingredients > D005503 - Food Additives > D005505 - Food Coloring Agents D004396 - Coloring Agents
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide
2-(4-chlorophenoxy)-N-[[4-(3-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]acetamide
1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridin-1-ium-3,5-dicarbothioate
(11-Methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-14-yl) hydrogen sulate
(Z)-3,4,4,5,5,6,6,7,7,8,8,9,9,9-tetradecafluoronon-2-enoic acid
dipotassium clorazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
dADP(3-)
A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of 2-deoxyadenosine 5-diphosphate (dADP); major species at pH 7.3.
10074-A4
10074-A4 is a c-Myc inhibitor. 10074-A4 could bind to c-Myc370-409 at different sites along the peptide chain. 10074-A4 has anticancer effects[1][2].
3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene-4,11-diol
C15H22Br2O3 (407.99355819999994)
4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undec-3-en-2-one
(5r)-5-[(1s,2e)-10,10-dibromo-1-methoxydeca-2,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(11e)-16-bromo-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
(5r)-5-[(1e,3s)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)